Delpharm, a CDMO, has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville. This announcement ensures that Delpharm will maintain its Boucherville site within Canada, helping to secure the local supply chain for sterile injectable medicines. The Boucherville plant currently produces 20 of the 100 critical medicines vital to the Canadian healthcare system, making it a key player in supplying essential generic products for surgery...